Novelix Pharmaceuticals Limited (BOM:536565)
India
· Delayed Price · Currency is INR 53.90
+0.80 (1.51%)
At close: Mar 10, 2026
Novelix Pharmaceuticals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 6.79 | 1.18 | 2.75 | 28.9 | 20.8 | Upgrade
|
| Short-Term Investments | - | - | 25 | 25 | - | - | Upgrade
|
| Trading Asset Securities | - | - | 8.73 | 3.91 | 1.19 | 2.48 | Upgrade
|
| Cash & Short-Term Investments | 14.5 | 6.79 | 34.91 | 31.66 | 30.09 | 23.28 | Upgrade
|
| Cash Growth | 855.66% | -80.56% | 10.26% | 5.22% | 29.25% | 94.62% | Upgrade
|
| Accounts Receivable | - | 181.37 | 0.13 | 1.9 | 12.32 | 13.81 | Upgrade
|
| Other Receivables | - | 1.58 | 2.83 | 3.66 | 3.89 | 4.76 | Upgrade
|
| Receivables | - | 253.18 | 2.97 | 6.34 | 20.38 | 42.22 | Upgrade
|
| Inventory | - | 8.43 | 3.21 | 4.29 | 8.77 | 6.78 | Upgrade
|
| Prepaid Expenses | - | 0.18 | 0.01 | 0.13 | 0.08 | 0.02 | Upgrade
|
| Other Current Assets | - | 0.75 | 0.2 | - | -0 | 1 | Upgrade
|
| Total Current Assets | - | 269.33 | 41.3 | 42.43 | 59.31 | 73.3 | Upgrade
|
| Property, Plant & Equipment | - | 1.86 | 1.18 | 1.74 | 4.55 | 16.2 | Upgrade
|
| Long-Term Investments | - | 0.43 | 30.64 | 27.75 | 4.22 | 3.9 | Upgrade
|
| Other Intangible Assets | - | 0 | 0 | 0 | 0.11 | 0.32 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.45 | 0.54 | 0.65 | 0.66 | - | Upgrade
|
| Other Long-Term Assets | - | 0 | - | - | 18.54 | 2 | Upgrade
|
| Total Assets | - | 272.06 | 73.65 | 72.57 | 87.38 | 95.73 | Upgrade
|
| Accounts Payable | - | 93.01 | 0.03 | 0.54 | 8.83 | 21.46 | Upgrade
|
| Accrued Expenses | - | 3.36 | 0.07 | 0.07 | 0.09 | 0.13 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.34 | - | Upgrade
|
| Current Income Taxes Payable | - | 0.3 | - | - | - | - | Upgrade
|
| Other Current Liabilities | - | - | 0 | 0.01 | 0.05 | 0.16 | Upgrade
|
| Total Current Liabilities | - | 96.67 | 0.1 | 0.62 | 9.29 | 21.75 | Upgrade
|
| Long-Term Debt | - | - | - | - | 1.31 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.33 | Upgrade
|
| Total Liabilities | - | 96.67 | 0.1 | 0.62 | 10.6 | 22.08 | Upgrade
|
| Common Stock | - | 99.5 | 81 | 81 | 81 | 81 | Upgrade
|
| Additional Paid-In Capital | - | 94.65 | 12.15 | 12.15 | 12.15 | 12.15 | Upgrade
|
| Retained Earnings | - | -18.76 | -19.6 | -24.32 | -22.74 | -28.14 | Upgrade
|
| Comprehensive Income & Other | - | - | - | 3.12 | 3.63 | 3.63 | Upgrade
|
| Total Common Equity | 256.1 | 175.39 | 73.55 | 71.95 | 74.04 | 68.65 | Upgrade
|
| Minority Interest | - | - | - | - | 2.74 | 5.01 | Upgrade
|
| Shareholders' Equity | 256.1 | 175.39 | 73.55 | 71.95 | 76.78 | 73.65 | Upgrade
|
| Total Liabilities & Equity | - | 272.06 | 73.65 | 72.57 | 87.38 | 95.73 | Upgrade
|
| Total Debt | - | - | - | - | 1.65 | - | Upgrade
|
| Net Cash (Debt) | 14.5 | 6.79 | 34.91 | 31.66 | 28.44 | 23.28 | Upgrade
|
| Net Cash Growth | 855.66% | -80.56% | 10.26% | 11.31% | 22.18% | 442.70% | Upgrade
|
| Net Cash Per Share | 0.96 | 0.72 | 3.35 | 3.91 | 3.51 | 2.87 | Upgrade
|
| Filing Date Shares Outstanding | 17.32 | 9.95 | 8.1 | 8.1 | 8.1 | 8.1 | Upgrade
|
| Total Common Shares Outstanding | 17.32 | 9.95 | 8.1 | 8.1 | 8.1 | 8.1 | Upgrade
|
| Working Capital | - | 172.66 | 41.2 | 41.81 | 50.02 | 51.55 | Upgrade
|
| Book Value Per Share | 17.77 | 17.63 | 9.08 | 8.88 | 9.14 | 8.47 | Upgrade
|
| Tangible Book Value | 249 | 175.39 | 73.55 | 71.95 | 73.93 | 68.32 | Upgrade
|
| Tangible Book Value Per Share | 17.28 | 17.63 | 9.08 | 8.88 | 9.13 | 8.43 | Upgrade
|
| Buildings | - | - | 1.43 | 1.43 | 1.43 | - | Upgrade
|
| Machinery | - | - | 11.85 | 12.04 | 14.54 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.